2,680
Participants
Start Date
November 30, 2013
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
QIVc
Novartis Investigational Quadrivalent Vaccine
TIV1c
Licensed Influenza Vaccine
TIV2c
Novartis Investigational Vaccine
Endwell
Rochester
Rockville
Cary
Raleigh
Charlotte
Wilmington
Mt. Pleasant
Anderson
Melbourne
Hollywood
Coral Gables
South Miami
West Palm Beach
Huntsville
Mishawaka
Council Bluffs
Edina
Dakota Dunes
Peoria
Newton
Wichita
Wichita
Bellevue
Omaha
Metairie
Oklahoma City
Dallas
Fort Worth
San Angelo
Austin
Austin
South Jordan
Salt Lake City
Salt Lake City
Salt Lake City
Phoenix
San Diego
Anaheim
Warwick
Lead Sponsor
Novartis Vaccines
INDUSTRY